Skip to main content

Incannex Healthcare Inc.

IXHL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001873875

No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Incannex Healthcare Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of IXHL: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders612+6
Shares502.3K1.02M+520.2K (+103.6%)
Value$339.3K$220.2K−$119.1K (−35.1%)

New holders (8)

Institutions that held Incannex Healthcare Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to IXHL in Q2 2025
InstitutionSharesValue% of portfolio
LPL Financial LLC323,900$69.9K0.00%
Wealth Enhancement Advisory Services, LLC91,467$19.2K0.00%
Commonwealth Equity Services, LLC55,275$12.0K0.00%
Scientech Research LLC39,504$8.52K0.00%
Citigroup Inc26,474$5.71K0.00%
Revisor Wealth Management LLC14,042$3.16K0.00%
SBI Securities Co., Ltd.4,152$8960.00%
Iron Horse Wealth Management, LLC100$220.00%

Sold out (2)

Institutions that held Incannex Healthcare Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of IXHL in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Citadel Advisors LLC102,873$69.6K
Bridgeway Capital Management, LLC25,000$16.9K